Table 3.
Maximum proposed use levels of the NFs and their main components
| Age groups | Maximum use level (g/day) | ||
|---|---|---|---|
| NF | HiMO | ||
| 2’‐FL/DFL | Infants ≤ 6 months | 1.6 | 1.30 2’‐FL; 0.18 DFL a |
| Infants > 6 months | 1.2 | 0.97 2’‐FL; 0.13 DFL a | |
| LNT | Infants ≤ 6 months | 1.0 b | 0.8 LNT |
| Infants > 6 months | 0.8 b | 0.6 LNT | |
2’‐FL: 2’‐fucosyllactose; DFL: difucosyllactose; LNT: lacto‐N‐tetraose; NF: novel food; HiMO: human identical milk oligosaccharide.
a
Values estimated considering the average concentration of 2’‐FL and DFL (81 and 11% w/w DM, respectively) in the NF (EFSA NDA Panel, 2019a).
b
Values estimated considering the average concentration of LNT (78% w/w DM) in the NF (EFSA NDA Panel, 2019b).